Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00372167
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
HA3![]() | N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2- a]pyrazin-7(8H)-yl)carbonyl]thiophene- 2-carboxamide | A,B | 2VQV | 0.7 | ![]() |
HA3![]() | N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2- a]pyrazin-7(8H)-yl)carbonyl]thiophene- 2-carboxamide | A | 2VQM | 0.7 | ![]() |
PB2![]() | 1-(biphenyl-4-ylmethyl)-1H-imidazole | A,B,C,D | 3G93 | 0.75 | ![]() |
PB2![]() | 1-(biphenyl-4-ylmethyl)-1H-imidazole | A,B,C,D | 3G5N | 0.75 | ![]() |
FR8![]() | 1-((1R)-1-(HYDROXYMETHYL)-3-{6- [(5-PHENYLPENTANOYL)AMINO]-1H-INDOL- 1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1QXL | 0.71 | ![]() |
IM1![]() | B | 1BDQ | 0.71 | ![]() | |
IM1![]() | A,B | 1TCW | 0.71 | ![]() | |
IM1![]() | A | 1SBG | 0.71 | ![]() | |
IM1![]() | A,B | 1BDL | 0.71 | ![]() | |
IM1![]() | B | 1BDR | 0.71 | ![]() | |
IM1![]() | A | 1TCX | 0.71 | ![]() | |
I19![]() | N-(4-{[(3S)-3-(dimethylamino)pyrrolidin- 1-yl]carbonyl}phenyl)-5-fluoro- 4-[2-methyl-1-(1-methylethyl)-1H- imidazol-5-yl]pyrimidin-2-amine | A | 2W17 | 0.73 | ![]() |
406![]() | N-[3-(4,5'-BIPYRIMIDIN-2-YLAMINO)- 4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN- 1-YL]METHYL}-3-(TRIFLUOROMETHYL)BENZAMIDE | A,B | 2E2B | 0.71 | ![]() |
FR3![]() | 1-((1R)-1-(HYDROXYMETHYL)-3-(1- NAPHTHYL)PROPYL)-1H-IMIDAZOLE-4- CARBOXAMIDE | A | 1NDY | 0.73 | ![]() |
FR2![]() | 1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDW | 0.73 | ![]() |
MIM![]() | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A | 2NMT | 0.78 | ![]() |
MIM![]() | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A,B | 1IYK | 0.78 | ![]() |
FTI![]() | 1-{2-[3-(4-CYANO-BENZYL)-3H-IMIDAZOL- 4-YL]-ACETYL}-5-NAPHTHALEN-1-YL- 1,2,3,6-TETRAHYDRO-PYRIDINE-4-CARBONITRILE | B | 1N9A | 0.72 | ![]() |
NIL![]() | Nilotinib | A,B,C,D | 3CS9 | 0.72 | ![]() |
NIL![]() | Nilotinib | A | 3GP0 | 0.72 | ![]() |
IFC![]() | N-[2-methyl-5-({[3-(4-methyl-1H- imidazol-1-yl)-5-(trifluoromethyl)phenyl]carbonyl}amino)phenyl]isoxazole- 5-carboxamide | A | 3DZQ | 0.73 | ![]() |
FR6![]() | 1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 2E1W | 0.73 | ![]() |
3MN![]() | 3-({3-[3-(1H-IMIDAZOL-1-YL)PROPYL]- 5-METHYL-5-(1-NAPHTHYL)-2,4-DIOXOIMIDAZOLIDIN- 1-YL}METHYL)BENZONITRILE | B | 2F0Y | 0.77 | ![]() |
TMI![]() | 1-[PHENYL-(4-PHENYLPHENYL)-METHYL]IMIDAZOLE | A | 2BDM | 0.76 | ![]() |
IH4![]() | N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2- PHENYLETHYL) | A | 2BJU | 0.76 | ![]() |
MPY![]() | (3E)-N-(2,6-DIETHYLPHENYL)-3-{[4- (4-METHYLPIPERAZIN-1-YL)BENZOYL]IMINO}PYRROLO[3,4- C]PYRAZOLE-5(3H)-CARBOXAMIDE | A,B,C,D,E,F | 2BMC | 0.71 | ![]() |
FR4![]() | 1-((1R)-1-(HYDROXYMETHYL)-3-{6- [(3-PHENYLPROPANOYL)AMINO]-1H-INDOL- 1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1UML | 0.71 | ![]() |
1BN![]() | 1-BENZYL-1H-IMIDAZOLE | A,B | 2AFX | 0.72 | ![]() |
MPZ![]() | 4-[(4-METHYLPIPERAZIN-1-YL)METHYL]- N-{3-[(4-PYRIDIN-3-YLPYRIMIDIN- 2-YL)AMINO]PHENYL}BENZAMIDE | A | 1Y57 | 0.7 | ![]() |